Skip to main content

Hematopoietic Cell Transplantation Recipient clinical trials at UCSF
1 in progress, 1 open to new patients

  • High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

    open to eligible people ages 3 years to 17 years

    This phase II randomized trial studies how well high dose flu vaccine works in treating children who have undergone done stem cell transplant. Higher dose flu vaccine may build a better immune response and may provide better protection against the flu than the standard vaccine.

    San Francisco, California and other locations